Related Experiment Videos
An experimental model for advanced ovarian cancer
T Sugiyama1, T Nishida, D Yokota
1Department of Obstetrics and Gynecology, Kurume University, School of Medicine, Japan.
The Kurume Medical Journal
|January 1, 1990
Summary
This study developed a rat ovarian cancer model for advanced epithelial carcinoma research. Preliminary cisplatin therapy results show promise for treating late-stage intraperitoneal cancer.
Area of Science:
- Oncology
- Animal Models
- Cancer Biology
Background:
- Ovarian cancer remains a significant health challenge, particularly in advanced stages.
- Effective experimental models are crucial for developing new therapeutic strategies.
Purpose of the Study:
- To establish and characterize an intraperitoneal ovarian cancer model in Wistar rats.
- To evaluate the model's suitability for preclinical therapeutic studies.
Main Methods:
- Intraperitoneal transplantation of an adenocarcinoma derived from primary ovarian cancer in Wistar rats.
- Observation of tumor development, ascites formation, and morphological/biological behavior.
- Preliminary assessment of cisplatin therapy efficacy.
Main Results:
- Tumor development and ascites occurred in 62% of female rats within 4-6 weeks.
- The transplanted tumor exhibited morphology and behavior similar to human ovarian cancer.
- Cisplatin therapy showed preliminary promise in this advanced-stage cancer model.
Conclusions:
- The Wistar rat intraperitoneal ovarian cancer model closely mimics human advanced-stage disease.
- This model is suitable for experimental therapeutic studies of advanced epithelial carcinoma.
- The model supports preliminary investigations into cisplatin's efficacy in advanced ovarian cancer.